a Study of the Epigenetic Alterations that Result in Cardiac Hypertrophy
(SEARCH)
Start date: Apr 1, 2010,
End date: Mar 31, 2012
PROJECT
FINISHED
"Heart failure is a major cause of mortality and morbidity, and often the consequence of pathological cardiac hypertrophy. Upon entering hypertrophy, cells undergo a vast transcriptional remodelling, with thousands of genes being either up- or down-regulated. In the last years it became evident that epigenetic modifications are an important determinant of transcriptional changes, and several lines of evidence demonstrate that epigenome modulating enzymes are implicated in cardiac hypertrophy. In the present project we propose to study transcriptional repression by DNA and histone methylation. We will map these modifications and use this map to identify and study the methyl transferases, transcription factors and pathways that underlie these modifications using a systems-biology approach. The insight that is to be anticipated from this study will not only enhance our understanding of transcription regulation in hypertrophy, it can also provide a novel entry point for strategies to treat this disorder."
Get Access to the 1st Network for European Cooperation
Log In
or
Create an account
to see this content
Coordinator
THE BABRAHAM INSTITUTE
€ 171 740,80- Fang Gao
- Babraham Hall CB22 3AT CAMBRIDGE (United Kingdom)